TABLE 1.
Children enrolled from birth and up to 28 days of age (birth cohort) |
Children enrolled after 28 days of age (older cohort) HIV-1+ (n = 205) |
||||||
---|---|---|---|---|---|---|---|
Characteristic | HIV-1+ (n = 93) | HIV-1− (n = 463) | Survivorsa (n = 134) | Nonsurvivorsa (n = 71) | |||
Race | |||||||
African-American | 41 | (44.1) | 245 (52.9) | 59 | (44.0) | 30 | (42.3) |
Hispanic | 32 | (34.4) | 138 (29.8) | 48 | (35.8) | 34 | (47.9) |
White | 15 | (16.1) | 54 (11.7) | 22 | (16.4) | 6 | (8.5) |
Other | 5 | (5.4) | 26 (5.6) | 5 | (3.7) | 1 | (1.4) |
Sex | |||||||
Male | 44 | (47.3) | 249 (53.8) | 60 | (44.8) | 34 | (47.9) |
Female | 49 | (52.7) | 214 (46.2) | 74 | (55.2) | 37 | (52.1) |
CDC Pediatric Disease Classification (1994)b | |||||||
Asymptomatic | 59 | (63.4) | 20 | (14.9) | 5 | (7.0) | |
Mild (Category A) | 16 | (17.2) | 31 | (23.1) | 4 | (5.6) | |
Moderate (Category B) | 11 | (11.8) | 25 | (18.7) | 10 | (14.1) | |
Severe (Category C) | 7 | (7.5) | 58 | (43.3) | 52 | (73.2) |
Note: Figures given represent frequency with percent given in parentheses.
Defined at end of 5-year study regardless of age at enrollment.
Most severe symptom status by 3 months of age for HIV-1+ children followed from birth and at the time of enrollment for the older HIV-1+ cohort (median enrollment age = 23 months).20